Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
<h3>Introduction</h3><p dir="ltr">Acute myeloid leukemia (AML) is a significant hematological malignancy in the United States, with a high mortality rate and limited treatment options. CAR T-cell therapy, a new and promising treatment, is being investigated for its effica...
Saved in:
| Main Author: | Mahmoud M. Morsy (18560491) (author) |
|---|---|
| Other Authors: | Ahmed Y. Azzam (14267391) (author), Osman Elamin (18560494) (author), Adam Elswedy (18560497) (author), Abdulqadir J. Nashwan (11659453) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myelomastocytic transformation in chronic myeloid leukemia blast phase: A case report
by: Abdulrahman F. Al-Mashdali (17148316)
Published: (2025) -
Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase
by: Mohamed A. Yassin (16322749)
Published: (2021) -
Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis
by: Fateen Ata (12217764)
Published: (2022) -
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
by: Luisa Tomasello (702932)
Published: (2020) -
Targeting human acute myeloid leukemia cells using human recombinant arginase I (Co) - PEG5000 [HuArgl (Co) - PEG5000] - induced arginine depletion. (c2013)
by: Tanios, Rita Farid
Published: (2013)